Related references
Note: Only part of the references are listed.Lecanemab in Early Alzheimer's Disease
Christopher H. van Dyck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab
Mingchao Shi et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Eric McDade et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-beta-Amyloid Immunotherapy
So Yeong Jeong et al.
NEUROLOGY (2022)
Estimated Annual Spending on Aducanumab in the US Medicare Program
John N. Mafi et al.
JAMA HEALTH FORUM (2022)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease
Konstantinos Avgerinos et al.
AGEING RESEARCH REVIEWS (2021)
Biomarkers for neurodegenerative diseases
Oskar Hansson
NATURE MEDICINE (2021)
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Morvane Colin et al.
ACTA NEUROPATHOLOGICA (2020)
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
Martin Tolar et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial
Jeff D. Williamson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status
Julien Delrieu et al.
ALZHEIMERS & DEMENTIA (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Dementia is not synonymous with Alzheimer's disease
Clifford R. Jack et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
Christopher H. van Dyck
BIOLOGICAL PSYCHIATRY (2018)
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
Sandrine Andrieu et al.
LANCET NEUROLOGY (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial
Eric P. Moll van Charante et al.
LANCET (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Tiia Ngandu et al.
LANCET (2015)
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares et al.
Current Alzheimer Research (2013)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Share Paper
